Literature DB >> 22052330

Reversal of fetal ductal constriction after maternal restriction of polyphenol-rich foods: an open clinical trial.

P Zielinsky1, A L Piccoli, J L L Manica, L H Nicoloso, I Vian, L Bender, P Pizzato, M Pizzato, F Swarowsky, C Barbisan, A Mello, S C Garcia.   

Abstract

OBJECTIVE: To test the hypothesis that maternal restriction of polyphenol-rich foods (PRF), which, like non-steroidal anti-inflammatory drugs (NSAID), inhibit prostaglandin synthesis in the third trimester, reverse fetal ductal constriction (DC). STUDY
DESIGN: An open clinical trial of 51 third trimester fetuses with DC with no history of NSAID intake was designed. All mothers were submitted to a food frequency questionnaire and were oriented to withdrawl PRF, being reassessed after 3 weeks. Doppler parameters were assessed before and after discontinuation of these substances. A control group of 26 third trimester normal fetuses, with no ductus arteriosus (DA) constriction, in which no dietary intervention was offered, was reviewed after 3 weeks. Student's t-test and Wilcoxon's test were used. RESULT: Mean gestational age was 32±3 weeks (28 to 37 weeks). After discontinuation of PRF (≥3 weeks), 48/51 fetuses (96%) showed complete reversal of DC, with decrease in mean ductal systolic velocity (1.74±0.20 m s(-1) to 1.31±0.34 m s(-1), P<0.001), mean diastolic velocity (0.33±0.09 m s(-1) to 0.21±0.07 m s(-1), P<0.001) and mean right to left ventricular dimension ratio (1.37±0.26 to 1.12±0.17, P<0.001) and increase in mean ductal pulsatility index (PI) (1.98±0.36 to 2.46±0.23, P<0.001). Median daily maternal consumption of PRF was 286 mg per day and decreased after orientation to 0 mg per day, P<0.001. In the control group, with GA of 32±4 w (29-37 w), there was no significant differences in median daily maternal consumption of PRF, mean ductal systolic velocitiy, diastolic velocity, PI and right ventricular to left ventricular diameter ratio (RV/LV) ratio.
CONCLUSION: Reduction of maternal PRF intake during pregnancy, especially in the third trimester, is followed by complete reversal of DC (wide open DA), which may influence maternal dietary habits in late pregnancy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22052330     DOI: 10.1038/jp.2011.153

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  10 in total

1.  Maternal paracetamol intake and fetal ductus arteriosus constriction/closure: comprehensive signal evaluation using the Austin Bradford Hill criteria.

Authors:  Manfred Hauben; Stephen Bai; Eric Hung; Kasia Lobello; Charles Tressler; Vincent P Zucal
Journal:  Eur J Clin Pharmacol       Date:  2021-01-07       Impact factor: 2.953

Review 2.  Genetics of the patent ductus arteriosus (PDA) and pharmacogenetics of PDA treatment.

Authors:  Tamorah R Lewis; Elaine L Shelton; Sara L Van Driest; Prince J Kannankeril; Jeff Reese
Journal:  Semin Fetal Neonatal Med       Date:  2018-02-24       Impact factor: 3.926

3.  Maternal ingestion of cocoa causes constriction of fetal ductus arteriosus in rats.

Authors:  Paulo Zielinsky; Felipe Villa Martignoni; Melissa Markoski; Kelly Pozzer Zucatti; Gabriela Dos Santos Marinho; Gabriela Pozzobon; Pedro Rafael Magno; Victória de Bittencourt Antunes; Natassia Miranda Sulis; Alexandra Cardoso; Daniel Mattos; Alexandre Antônio Naujorks; Anize Delfino von Frankenberg; Izabele Vian
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

Review 4.  Prenatal effects of maternal consumption of polyphenol-rich foods in late pregnancy upon fetal ductus arteriosus.

Authors:  Paulo Zielinsky; Stefano Busato
Journal:  Birth Defects Res C Embryo Today       Date:  2013-12

5.  Deleterious effects of maternal ingestion of cocoa upon fetal ductus arteriosus in late pregnancy.

Authors:  Paulo Zielinsky; Felipe V Martignoni; Izabele Vian
Journal:  Front Pharmacol       Date:  2014-12-22       Impact factor: 5.810

6.  Brazilian Fetal Cardiology Guidelines - 2019.

Authors:  Simone R F Fontes Pedra; Paulo Zielinsky; Cristiane Nogueira Binotto; Cristiane Nunes Martins; Eduardo Sérgio Valério Borges da Fonseca; Isabel Cristina Britto Guimarães; Izabele Vian da Silveira Corrêa; Karla Luiza Matos Pedrosa; Lilian Maria Lopes; Luiz Henrique Soares Nicoloso; Marcia Ferreira Alves Barberato; Marina Maccagnano Zamith
Journal:  Arq Bras Cardiol       Date:  2019-06-06       Impact factor: 2.000

7.  Cardiac Function Assessment in Fetuses With Ductus Arteriosus Constriction: A Two-Dimensional Echocardiography and FetalHQ Study.

Authors:  Jing Ma; Haiyan Cao; Liu Hong; Juanjuan Liu; Xiaoyan Song; Jiawei Shi; Yi Zhang; Li Cui; Li Zhang; Mingxing Xie
Journal:  Front Cardiovasc Med       Date:  2022-07-26

8.  Fetal adverse effects following NSAID or metamizole exposure in the 2nd and 3rd trimester: an evaluation of the German Embryotox cohort.

Authors:  Katarina Dathe; Johanna Frank; Stephanie Padberg; Stefanie Hultzsch; Evelin Beck; Christof Schaefer
Journal:  BMC Pregnancy Childbirth       Date:  2022-08-26       Impact factor: 3.105

Review 9.  Foetal ductus arteriosus constriction unrelated to non-steroidal anti-Inflammatory drugs: a case report and literature review.

Authors:  Giovanna Battistoni; Ramona Montironi; Jacopo Di Giuseppe; Luca Giannella; Giovanni Delli Carpini; Alessandra Baldinelli; Marco Pozzi; Andrea Ciavattini
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

10.  Maternal restriction of polyphenols and fetal ductal dynamics in normal pregnancy: an open clinical trial.

Authors:  Paulo Zielinsky; Antônio Luiz Piccoli; Izabele Vian; Ana Maria Zílio; Alexandre Antônio Naujorks; Luiz Henrique Nicoloso; Carolina Weiss Barbisan; Stefano Busato; Mauro Lopes; Caroline Klein
Journal:  Arq Bras Cardiol       Date:  2013-08-14       Impact factor: 2.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.